4//SEC Filing
Firmani Lori 4
Accession 0000905718-20-001130
CIK 0001566373other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 11:12 AM ET
Size
16.9 KB
Accession
0000905718-20-001130
Insider Transaction Report
Form 4
Firmani Lori
VP of Finance and Treasurer
Transactions
- Sale
Common Stock
2020-11-20$4.76/sh−175$833→ 17,867 total - Exercise/Conversion
Restricted Stock Units
2020-11-19−3,750→ 0 total→ Common Stock (3,750 underlying) - Award
Common Stock
2020-11-19+12,500→ 18,042 total - Exercise/Conversion
Common Stock
2020-11-19+3,750→ 5,542 total
Footnotes (3)
- [F1]Restricted stock units ("RSUs") converted into common stock on a one-for-one basis.
- [F2]All unvested issued and outstanding RSUs accelerated and vested in full in connection with the closing of the business combination with F-star Therapeutics Limited.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.64 to $4.88 per share. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
Issuer
F-star Therapeutics, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001808248
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 11:12 AM ET
- Size
- 16.9 KB